Cargando…

Multitargeting strategy using lenvatinib and golvatinib: Maximizing anti-angiogenesis activity in a preclinical cancer model

Almost all cancers show intrinsic and/or evasive resistance to vascular endothelial growth factor (VEGF) inhibitors by multiple mechanisms. Serum angiopoietin-2 (Ang2) level has been proposed as a potential biomarker of VEGF inhibitor response in several cancers. From these clinical observations, th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakazawa, Youya, Kawano, Satoshi, Matsui, Junji, Funahashi, Yasuhiro, Tohyama, Osamu, Muto, Hiroki, Nakagawa, Takayuki, Matsushima, Tomohiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4399030/ https://www.ncbi.nlm.nih.gov/pubmed/25458359 http://dx.doi.org/10.1111/cas.12581

Ejemplares similares

Lenvatinib in combination with golvatinib overcomes hepatocyte growth factor pathway-induced resistance to vascular endothelial growth factor receptor inhibitor
por: Nakagawa, Takayuki, et al.
Publicado: (2014)

Antitumor Activity of Lenvatinib (E7080): An Angiogenesis Inhibitor That Targets Multiple Receptor Tyrosine Kinases in Preclinical Human Thyroid Cancer Models
por: Tohyama, Osamu, et al.
Publicado: (2014)

Targeting of tumor growth and angiogenesis underlies the enhanced antitumor activity of lenvatinib in combination with everolimus
por: Matsuki, Masahiro, et al.
Publicado: (2017)

Lenvatinib, an angiogenesis inhibitor targeting VEGFR/FGFR, shows broad antitumor activity in human tumor xenograft models associated with microvessel density and pericyte coverage
por: Yamamoto, Yuji, et al.
Publicado: (2014)

Lenvatinib inhibits angiogenesis and tumor fibroblast growth factor signaling pathways in human hepatocellular carcinoma models
por: Matsuki, Masahiro, et al.
Publicado: (2018)

Eribulin mesylate reduces tumor microenvironment abnormality by vascular remodeling in preclinical human breast cancer models
por: Funahashi, Yasuhiro, et al.
Publicado: (2014)

Immunomodulatory activity of lenvatinib contributes to antitumor activity in the Hepa1‐6 hepatocellular carcinoma model
por: Kimura, Takayuki, et al.
Publicado: (2018)

Synergistic Effect of Lenvatinib and Chemotherapy in Hepatocellular Carcinoma Using Preclinical Models
por: Wang, Mingxun, et al.
Publicado: (2023)

Treatment of Non-Alcoholic Steatosis: Preclinical Study of a New Nutraceutical Multitarget Formulation
por: Micheli, Laura, et al.
Publicado: (2020)

Lenvatinib plus anti-PD-1 antibody combination treatment activates CD8(+) T cells through reduction of tumor-associated macrophage and activation of the interferon pathway
por: Kato, Yu, et al.
Publicado: (2019)

Efficacy of Combination Therapy with Lenvatinib and Radioactive Iodine in Thyroid Cancer Preclinical Model
por: Suzuki, Kensuke, et al.
Publicado: (2022)

Targeting Angiogenesis with Multitargeted Tyrosine Kinase Inhibitors in the Treatment of Non-Small Cell Lung Cancer
por: Scagliotti, Giorgio, et al.
Publicado: (2010)

Lenvatinib for Anaplastic Thyroid Cancer
por: Tahara, Makoto, et al.
Publicado: (2017)

“Statistics 103” for Multitarget Tracking
por: Mahler, Ronald
Publicado: (2019)

Multitarget Therapeutics for Neurodegenerative Diseases
por: Gabr, Moustafa T., et al.
Publicado: (2020)

Hippocampal Avoidance in Multitarget Radiosurgery
por: Gude, Zachary, et al.
Publicado: (2021)

A Definition of “Multitargeticity”: Identifying Potential Multitarget and Selective Ligands Through a Vector Analysis
por: Sánchez-Tejeda, Juan Francisco, et al.
Publicado: (2020)

Lenvatinib, a molecule with versatile application: from preclinical evidence to future development in anti-cancer treatment
por: Capozzi, Monica, et al.
Publicado: (2019)

Synergistic Effects of Lenvatinib (E7080) and MEK Inhibitors against Anaplastic Thyroid Cancer in Preclinical Models
por: Enomoto, Keisuke, et al.
Publicado: (2021)

Extracellular vesicles secreted from bone metastatic renal cell carcinoma promote angiogenesis and endothelial gap formation in bone marrow in a time-dependent manner in a preclinical mouse model
por: Takeda, Masashi, et al.
Publicado: (2023)

Towards Multitarget Testing in Molecular Microbiology
por: Steensels, Deborah, et al.
Publicado: (2013)

Multitarget therapeutic strategies for Alzheimer’s disease
por: Ibrahim, Mostafa M., et al.
Publicado: (2019)

Multitarget Molecular Hybrids of Cinnamic Acids
por: Peperidou, Aikaterini, et al.
Publicado: (2014)

Multitarget Approaches against Multiresistant Superbugs
por: Gray, Declan Alan, et al.
Publicado: (2020)

Selecting Multitarget Peptides for Alzheimer’s Disease
por: Kasus-Jacobi, Anne, et al.
Publicado: (2022)

Eribulin mesylate exerts specific gene expression changes in pericytes and shortens pericyte-driven capillary network in vitro
por: Agoulnik, Sergei I, et al.
Publicado: (2014)

Consensus Ensemble Multitarget Neural Network Model of Anxiolytic Activity of Chemical Compounds and Its Use for Multitarget Pharmacophore Design
por: Vassiliev, Pavel M., et al.
Publicado: (2023)

Maximizing the potential of aggressive mouse tumor models in preclinical drug testing
por: Elghetany, M. Tarek, et al.
Publicado: (2021)

Lenvatinib Might Induce Activation of Host Immunity in Patients with Hepatocellular Carcinoma
por: Nagai, Hidenari, et al.
Publicado: (2023)

Identification of a Common Pharmacophore for Binding to MMP2 and RGD Integrin: Towards a Multitarget Approach to Inhibit Cancer Angiogenesis and Metastasis
por: Baldini, Lorenzo, et al.
Publicado: (2022)

Lenvatinib-induced Interstitial Pneumonia in a Patient with Hepatocellular Carcinoma
por: Imakura, Takeshi, et al.
Publicado: (2021)

Inhibition of FGFR Reactivates IFNγ Signaling in Tumor Cells to Enhance the Combined Antitumor Activity of Lenvatinib with Anti-PD-1 Antibodies
por: Adachi, Yusuke, et al.
Publicado: (2022)

Curation and Analysis of Multitargeting Agents for Polypharmacological Modeling
por: Reddy, A. Srinivas, et al.
Publicado: (2014)

Small Multitarget Molecules Incorporating the Enone Moiety
por: Liargkova, Thalia, et al.
Publicado: (2019)

Exact Closed-Form Multitarget Bayes Filters
por: Mahler, Ronald
Publicado: (2019)

Memantine Derivatives as Multitarget Agents in Alzheimer’s Disease
por: Marotta, Giambattista, et al.
Publicado: (2020)

Plea for multitargeted interventions for severe COVID-19
por: Gaborit, Benjamin Jean, et al.
Publicado: (2020)

Multitargeting nature of muscarinic orthosteric agonists and antagonists
por: Myslivecek, Jaromir
Publicado: (2022)

Pharmacological Potential of Betulin as a Multitarget Compound
por: Adepoju, Feyisayo O., et al.
Publicado: (2023)

Relationship between adverse events associated with lenvatinib treatment for thyroid cancer and patient prognosis
por: Iwasaki, Hiroyuki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kcd86cggu1m26v9kudv72pqd59